Publicacións (32) Publicacións de Hortensia Álvarez Díaz

2024

  1. Laboratory Report of HIV-1 Low-Level Viremia

    Open Forum Infectious Diseases

2023

  1. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  2. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  3. Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

    Clinical Infectious Diseases

2022

  1. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study

    eClinicalMedicine, Vol. 52

  2. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

    The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049

  3. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  4. SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

    Microorganisms, Vol. 10, Núm. 1

  5. Valaciclovir como probable agente causal de síndrome confusional de un paciente en hemodiálisis

    Galicia Clínica, Vol. 83, Núm. 2, pp. 76-76

2020

  1. Invasive disease due to Streptococcus pyogenes: A household cluster in Northwest Spain

    European Journal of Internal Medicine

2019

  1. Clinical impact of virological failure and resistance analysis definitions used in pivotal clinical trials of initial antiretroviral treatment: a systematic review

    Salux: revista de ciencias y humanidades, Vol. 5, Núm. 1, pp. 15-16

  2. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

  3. Fanconi syndrome and tenofovir alafenamide

    Annals of Internal Medicine

  4. Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide

    Infection, Vol. 47, Núm. 1, pp. 115-119

2018

  1. Clinical impact of virological failure and resistance analysis definitions used in pivotal clinical trials of initial antiretroviral treatment: A systematic review

    AIDS Reviews, Vol. 20, Núm. 3, pp. 158-170

  2. Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges

    International Journal of STD and AIDS, Vol. 29, Núm. 9, pp. 933-936

  3. Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies

    Journal of Medical Virology, Vol. 90, Núm. 6, pp. 1094-1098

  4. Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 7, pp. 1617-1619

2017

  1. Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure

    Journal of Medical Virology, Vol. 89, Núm. 7, pp. 1304-1308

2016

  1. European mitochondrial haplogroups impact on liver fibrosis progression among HCV and HIV/HCV-coinfected patients from Northwest Spain

    Journal of Acquired Immune Deficiency Syndromes, Vol. 73, Núm. 2, pp. 149-153